maintenance-phase renal failure (predialysis renal failure)
Conditions
Interventions
None listed
Sponsors
Scientific Advisory Committee (SAC)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients consenting to the present study of those registered in the Japan Erythropoietin Treatment Study for Target Hb and Survival (JET Study).
Exclusion criteria
Exclusion criteria: no criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Risk analysis of background factors affecting vital prognosis following initiation of hemodialysis is performed by the appropriate technique, such as Cox's regression model. | — |
Secondary
| Measure | Time frame |
|---|---|
| Additionally, the same analysis is carried out with hospitalization as is done for vital prognosis. | — |
Countries
Japan
Contacts
Public ContactSHIGERU NIHOJIMA
Chugai Pharmaceutical CO.LTD. PHARMACOVIGILANCE Dept.
Outcome results
None listed